Transplant medicine runs on decisions that change lives. We build the diagnostics that make those decisions clearer, grounded in genomics, honest about the numbers, and reachable wherever a patient is.
We resolve the biology at the level it actually happens, reading sequence and signal directly rather than inferring it from an ageing proxy.
Digital, calibrated results you can trust and compare, so a value means the same thing from one lab, one day, one patient to the next.
Diagnostics designed to travel, from the reference laboratory to clinics and communities that the newest tools too often leave behind.
Behind every result is a person waiting to hear whether their new organ is safe.
A transplant is a second chance, and protecting it is a lifelong act of vigilance. We design our diagnostics around that human reality: fewer invasive tests, earlier and clearer signals, and answers that reach the people who need them, not only those in the best-resourced hospitals.
Clarity is not a luxury in transplant care. It is the difference between watching and knowing.
The tools of genomics have transformed what a diagnostic test can see. We apply them to the questions transplant clinicians actually face, with a discipline that separates what is proven from what is promised, and never over-claims.
Whether you are a clinician, a research partner, an investor or a patient, we would like to hear from you.
